Burns, shocks and blood loss due to trauma or road accidents causes severe fluid loss from body,
which can be retained by giving IV solution to patients. Increasing incidents of burns, shocks and
excess fluid loss due to trauma and accidents are expected to boost the growth of IV solutions
market in near future. Rising prevalence of chronic diseases and surgeries are also expected to fuel
IV solution market as IV fluids are given to the patients suffering from chronic diseases for
recovery after the surgery. However, the presence of domestic players which provide low quality
products that does not provide optimum results are hampering the market growth.
Market Taxonomy
The intravenous solutions market is segmented on the basis of solution type, composition, and end
user
On the basis of solution type, the intravenous solutions market is segment into:
•Crystalloid solutions
•Colloid solutions
•Free H 2O solutions
•Blood products
On the basis of composition, the intravenous solutions market is segment into:
•Normal Saline (0.9% Normal Saline (0.9% NaCl)
•Hypertonic saline (3, 5, & 7.5%)
•Lactated Ringer’s
•Dextran
•D5W (5% dextrose in water)
•Whole blood
•Platelets
•Others
On the basis of end user, the intravenous solutions market is segment into:
•Hospitals
•Clinics
•Ambulatory surgery centers
•Others
For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/intravenous-solutions-market-1134
Asia Pacific is expected to dominate IV solution market due to high ratio of diseases related to
fluid loss
Regional market for the intravenous solutions market by Coherent Market Insights is segmented
into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Asia Pacific
expected to hold the dominant position in market due to highest rate of diarrhea, chronic diseases,
and increasing rate of surgeries. According to the United Nations International Children's
Emergency Fund (UNICEF) in 2016, every two children out of four in Asia is suffering from